The Yoon Lab has been working on stem cell research in various cardiovascular diseases. Our major research interest is to use stem cell technology to treat various cardiovascular diseases, and we have been developing and using different bone marrow-derived stem sell or progenitor cells for cardiovascular repair.

Dr. Yeo holds the titles of G.P. "Bud" Peterson and Valerie H. Peterson Endowed Professor, as well as Harris Saunders Jr. Endowed Professor, in the Woodruff School of Mechanical Engineering and the Coulter Department of Biomedical Engineering at Georgia Tech. He is also the director of the Wearable Intelligent Systems and Healthcare Center (WISH Center) and the KIAT-Georgia Tech Semiconductor Electronics Center (K-GTSEC). Dr. Yeo's research focuses on understanding the fundamentals of soft materials, deformable mechanics, interfacial physics, manufacturing, and the integration of hard and soft materials for the development of biomedical systems. He earned his Ph.D. in mechanical engineering and genome sciences from the University of Washington in Seattle and subsequently worked as a postdoctoral research fellow at the University of Illinois at Urbana-Champaign. With over 180 peer-reviewed publications, Dr. Yeo has contributed to many prestigious journals, including Nature Materials, Nature Machine Intelligence, Nature Communications, and Science Advances. He is an IEEE Senior Member and has received numerous awards, including the Visiting Professorship from the Institute Jean Lamour at the Université de Lorraine in France, the Lucy G. Moses Lectureship Award at the Mount Sinai School of Medicine, the NIH Trailblazer Young Investigator Award, the IEEE Outstanding Engineer Award, the Emory School of Medicine Research Award, the Imlay Innovation Award, the American Heart Association Innovative Project Award, the Sensors Young Investigator Award, the Med-X Young Investigator Award, and the Outstanding Service Award from the Korea Institute for Advancement of Technology, as well as the Outstanding Yonsei Scholar Award. Dr. Yeo is also the founder of two startup companies: Huxley Medical, Inc. and WisMedical, Inc.

Chunhui Xu, PhD, is a Professor in the Department of Pediatrics at Emory University School of Medicine and a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute. 

Research in Dr. Xu's laboratory is focused on human cardiomyocytes derived from human pluripotent stem cells, which hold promise for cardiac cell therapy, disease modeling, drug discovery, and the study of developmental biology. They are also collaborating with investigators at Georgia Tech, Emory University, and Children's Healthcare of Atlanta, to explore the application of nanotechnology and tissue engineering in stem cell research.

 Xing Xie is the Carlton S. Wilder Assistant Professor in the School of Civil and Environmental Engineering at Georgia Institute of Technology. Prior to joining Georgia Tech, he was a post-doctoral scholar at California Institute of Technology. He received his B.S. (2006) and M.S. (2008) degrees in Environmental Science & Engineering from Tsinghua University, and a second M.S. degree (2012) in Materials Science & Engineering and a Ph.D. degree (2014) in Civil & Environmental Engineering from Stanford University. His research focuses on the applications of innovative materials for sustainable and reliable water and energy. He has worked on many projects related to water treatment and reuse, microbial detection and quantification, energy and resource recovery, energy storage, etc. He has published more than 60 peer-reviewed articles with more than 6,000 citations

Anqi Wu is an Assistant Professor at the School of Computational Science and Engineering (CSE), Georgia Institute of Technology. She was a Postdoctoral Research Fellow at the Center for Theoretical Neuroscience, the Zuckerman Mind Brain Behavior Institute, Columbia University. She received her Ph.D. degree in Computational and Quantitative Neuroscience and a graduate certificate in Statistics and Machine Learning from Princeton University. Anqi was selected for the 2018 MIT Rising Star in EECS, 2022 DARPA Riser, and 2023 Alfred P. Sloan Fellow. Her research interest is to develop scientifically-motivated Bayesian statistical models to characterize structure in neural data and behavior data in the interdisciplinary field of machine learning and computational neuroscience. She has a general interest in building data-driven models to promote both animal and human studies in the system and cognitive neuroscience.

Xia is the Brock Family Chair and Georgia Research Alliance (GRA) Eminent Scholar in Nanomedicine in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University, with joint appointments in School of Chemistry and Biochemistry, and School of Chemical and Biomolecular Engineering. Professor Xia received his Ph.D. degree in Physical Chemistry from Harvard University (with Professor George M. Whitesides) in 1996, his M.S. degree in Inorganic Chemistry from University of Pennsylvania (with the late Professor Alan G. MacDiarmid, a Nobel Laureate in Chemistry, 2000) in 1993, and his B.S. degree in Chemical Physics from the University of Science and Technology of China (USTC) in 1987. He came to the United States of America in 1991. Xia has received a number of prestigious awards, including the 2013 Nano Today Award, the ACS National Award in the Chemistry of Materials (2013), Fred Kavli Distinguished Lecture in Nanoscience at the MRS Spring Meeting (2013), AIMBE Fellow (2011), MRS Fellow (2009 ), NIH Director's Pioneer Award (2006), ACS Leo Hendrik Baekeland Award (2005), Camille Dreyfus Teacher Scholar (2002), David and Lucile Packard Fellowship in Science and Engineering (2000), Alfred P. Sloan Research Fellow (2000), NSF Early Career Development Award (2000), ACS Victor K. LaMer Award (1999), and Camille and Henry Dreyfus New Faculty Award (1997). Xia has been an Associate Editor of Nano Letters since 2002, and has served on the Advisory Boards of Particle & Particle Systems Characterization (2013-), Chemical Physics Letters (2013-), Chemistry: A European Journal (2013-), Chinese Journal of Chemistry (2013-), Angewandte Chemie International Edition (2011-), Advanced Healthcare Materials (2011-, inaugural chairman of the advisory board), Accounts of Chemical Research (2010-), Cancer Nanotechnology (2010-), Chemistry: An Asian Journal (2010-), Journal of Biomedical Optics (2010-), Nano Research (2009-), Science of Advanced Materials (2009-), Nano Today (2006-), Chemistry of Materials (2005-2007), Langmuir (2005-2010, 2013-2015), International Journal of Nanotechnology (2004-), and Advanced Functional Materials (2001-). He has also served as a Guest Editor of special issues for Advanced Materials (six times), Advanced Functional Materials (one time), MRS Bulletin (one time), and Accounts of Chemical Research (one time).

Research in the Wu lab is mainly focused on mass spectrometry (MS)-based proteomics. They are developing innovative methods to globally identify and quantify proteins and their post-translational modifications (PTMs), including glycosylation and phosphorylation, and applying them for biomedical research. Protein PTMs plays essential roles in biological systems, and aberrant protein expression and modification are directly related to various human diseases, including cystic fibrosis, cancer and infectious diseases. Novel analytical methods will profoundly advance our understanding of protein function, which will lead to the identification of proteins or modified proteins as effective drug targets and the discovery of biomarkers for early disease detection.

Dr. Wood completed his graduate training at the Massachusetts Institute of Technology. While there he worked under the guidance of Drs. H. Harry Asada and Roger Kamm to develop and use microfluidics to identify mechanisms governing vascular geometry. 

During his postdoc, Dr. Wood worked under Dr. Kevin Haigis (Beth Israel Deaconess Medical Center and Harvard Medical School) and Dr. Douglas Lauffenburger (Massachusetts Institute of Technology) to use systems biology to identify novel signaling mechanisms driving neuronal death in Alzheimer's disease and epithelial cell death during intestinal inflammation.